Financial Statements and Supplementary Data.
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented.
This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2018 in the Annual Report on Form 10-K, filed on December 13, 2018.
The Consolidated Condensed Balance Sheet for October 31, 2018 was derived from audited financial statements.
All intercompany balances and transactions have been eliminated.
The reporting change had no impact to previously reported segment net revenue, consolidated net revenue, earnings from operations, net earnings or net earnings per share (“EPS”).We have increased our focus on Device as a Service as the market begins to shift to contractual solutions.
We believe that we are well positioned due to our competitive product lineup.
•In Personal Systems, we face challenges with industry component availability.
We are also seeing increases in commodity costs impacting our bill of materials.
We recognize revenue depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which we are expected to be entitled in exchange for those goods or services.Information with respect to this item may be found in Note 12, “Litigation and Contingencies” to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Item 1A.
Risk Factors.